- Open Access
Isabl Platform, a digital biobank for processing multimodal patient data
BMC Bioinformatics volume 21, Article number: 549 (2020)
The widespread adoption of high throughput technologies has democratized data generation. However, data processing in accordance with best practices remains challenging and the data capital often becomes siloed. This presents an opportunity to consolidate data assets into digital biobanks—ecosystems of readily accessible, structured, and annotated datasets that can be dynamically queried and analysed.
We present Isabl, a customizable plug-and-play platform for the processing of multimodal patient-centric data. Isabl's architecture consists of a relational database (Isabl DB), a command line client (Isabl CLI), a RESTful API (Isabl API) and a frontend web application (Isabl Web). Isabl supports automated deployment of user-validated pipelines across the entire data capital. A full audit trail is maintained to secure data provenance, governance and ensuring reproducibility of findings.
As a digital biobank, Isabl supports continuous data utilization and automated meta analyses at scale, and serves as a catalyst for research innovation, new discoveries, and clinical translation.
Genome profiling represents a critical pillar for clinical, translational, and basic research. With an ever expanding suite of high-throughput technologies , the pace at which the scientific community is generating data at scale has rapidly accelerated. This imposes demands for specialized expertise to support data processing and analysis . Importantly, the derivation of novel biological and clinical insights is increasingly reliant upon large and statistically powered datasets, rich metadata annotation (clinical, demographic, treatment, outcome) as well as integration of diverse data modalities generated across samples and patients (i.e. genomic, imaging) . Such high-dimensional data science is now embedded across disciplines, raising significant hopes for the development of artificial intelligence (AI) driven innovation in healthcare and research [3, 4]. However, for this aspiration to fully materialize there is a clear and unmet need for the development of AI-ready data architectures or digital biobanks.
Implementation of frameworks that operate in accordance with data processing best practices is important to secure governance and provenance of digital assets, ensure quality control, and deliver reproducible findings. Analysis Information Management Systems (AIMS) [5,6,7,8,9] for Next Generation Sequencing (NGS) data represent integrative software solutions to support the lifecycle of genomics projects . While the democratization of NGS technologies has driven a development boom across data processing software [5, 9,10,11,12], only a few AIMS’s exist to support the increasing user-bases of NGS data and none to our knowledge incorporates multimodal data types in a patient or individual centric architecture.
We have developed Isabl, a plug-and-play platform for the processing of individual-centric multimodal data. Isabl is designed to support: (1) management of data assets according to the FAIR  principles (Findable, Interoperable, Accessible, Reusable), (2) automated deployment of data processing applications following the DATA  reproducibility checklist (Documentation, Automation, Traceability, and Autonomy); and, (3) advanced integrations with institutional information systems across diverse data types (i.e. clinical and biospecimen databases). To support flexible workflows Isabl is built upon a customizable framework, that enables end-users to specify metadata and pipeline implementation. In addition, we present a pipeline development methodology that is guided by the principles of containerization , continuous integration, version control, and the separation of analysis and execution logic. Here we provide a framework for the development of digital biobanks—patient-centric ecosystems of structured, annotated, and linked data that is readily computable upon, mined, and visualized.
Isabl is composed of four main microservices  (Fig. 1): (1) Isabl DB, an individual-centric database designed to track patients, samples, data, and results; (2) Isabl API, a RESTful API used to support authentication, interoperability, and integration with data processing environments and enterprise systems (e.g. clinical databases, visualization platforms; FAIR A1 ); (3) Isabl CLI, a Command Line Interface for managing and processing digital assets in a scalable data lake (i.e., genomic, imaging); and (4) Isabl Web, a frontend single page web application for data interrogation (for further technical details please refer to Isabl's documentation https://docs.isabl.io/quick-start; https://github.com/isabl-io/docs).
Isabl DB maps workflows for data provenance, processing, and governance (Fig. 2; FAIR R1 ). Metadata is captured across the following 5 thematic categories: (1) patient attributes; (2) samples, as biological material collected at a given time; (3) data properties including experimental technique, platform technology, and related parameters; (4) analytical workflows to account for a complete audit trail of versioned algorithms, related execution parameters, reference files, status tracking, and results deposition; (5) data governance information across projects and stakeholders (Additional file 1: Fig. S1; FAIR F2 ). All database records are assigned a globally unique and persistent identifier (UUID; FAIR F1 ), whilst individuals, samples, and experiments are further annotated with a customizable human friendly identifier (Additional file 1: Fig. S2). All metadata stored in Isabl DB is version controlled, all changes are recorded and previous states can be recovered. Management of phenotypic data such as disease ontology can be facilitated in three ways. Firstly, the disease schema can be customized with additional fields in agreement to end-user requirements. Secondly, ontologies from established databases such as OncoTree, (http://oncotree.mskcc.org) can be integrated (i.e. https://docs.isabl.io/data-model#sync-diseases-with-onco-tree). Lastly, proprietary schemas from institutional databases (i.e. ontologies implemented in local electronic medical records) can also be incorporated, thus allowing for direct linkage between results and related metadata at an institutional level.
Life cycle of bioinformatic operations
Isabl operations are organized in a three step process: (1) project initiation and metadata registration; (2) automated data import and processing; and, (3) results retrieval for analyses.
Projects and metadata registration
At project initiation, users specify a title, study description, and define stakeholders using Isabl Web. Individuals, samples and related experiments are registered through web forms, Excel batch submissions, or automated HTTP requests. Validation rules are enforced to ensure content quality, while account permissions and user roles guide data governance (project creation, edit, and data queries; see https://docs.isabl.io/production-deployment#multiuser-setup). To prevent dangling information, records can't be deleted if they are associated with other instances (e.g. a sample can't be removed if it has linked experiments). Furthermore, all database schemas can be extended with custom fields in order to address end-user metadata requirements.
Once information is registered, users can interrogate the entire digital real estate using Isabl Web. A single page portal is populated with interactive panels that become available as new information is requested (Fig. 3; https://demo.isabl.io). Tables directly wired to Isabl API, provide searching, filtering, and ordering capabilities across different schemas and are available throughout the application (e.g. Additional file 1: Fig. S3; FAIR F4).
Detail views are retrieved by clicking on any hyper-linked identifier within these tables. The project detail panel caters a birds-eye view across all analyses and experiments pertaining to a study (Additional file 1: Fig. S4). Similarly, the samples view provides an interactive, patient-centric, tree visualization that enables instant access to all assets generated on a given individual (Fig. 3a, b; Additional file 1: Fig. S5). Dashboards to explore metadata and access results are also provided (Additional file 1: Fig. S6).
Data import and registration
After metadata registration, the next step for an Isabl project is data import. Isabl CLI explores data deposition directories (i.e. sequencing core, data drives) identifying multimodal digital assets (i.e. genomic, imaging) relating to specific experiments and imports them into a scalable data directory (move or symlink; Additional file 1: Fig. S7). This process ensures that the link between data and metadata is stored in Isabl DB. Upon import, access permissions are configured and data related attributes are stored in the database (e.g. checksums, usage, location). Import status is updated in Isabl DB and displayed in Isabl Web.
In addition to data imported for analyses, Isabl CLI also supports the registration of auxiliary assets such as an assembly reference genomes, techniques reference data (e.g. BED files), and post-processing files (i.e. data relating to control cohorts). To secure data integrity, import operations and data ownership are limited to a single admin user (e.g. a shared Linux account managed by Isabl administrators). Importantly, import logic for data and auxiliary files is entirely customizable and can be tailored to end-user requirements (i.e. cloud storage).
Out of the box, Isabl CLI operates on local file systems using traditional unix commands such as mv, ln, cp, and rsync. Nevertheless, the Isabl data lake can be stored in cloud buckets like Amazon S3 (https://aws.amazon.com/s3), Google Storage Buckets (https://cloud.google.com/storage), or Azure Blobs (https://azure.microsoft.com/services/storage/blobs). Mechanisms to push and pull data to the cloud must be implemented by the user, although there are automated solutions such as Amazon FSx for Lustre (https://aws.amazon.com/fsx/lustre). When data is stored in the cloud, Isabl Web can be configured to retrieve and display results from these providers. Importantly, Isabl can compute on data located in a local file system, cloud based solutions or hybrid (local and cloud).
Deploying data processing tools at scale with Isabl applications
Isabl is a horizontally integrated digital biobank onto which existing or bespoke analytical applications can be docked and integrated in a way that confers sample-centric traceability to the analytical results. Upon data import, Isabl applications enable standardized deployment of data processing pipelines with a Software Development Kit (SDK; Fig. 4). Guided by experimental metadata in Isabl DB, applications construct, validate, and deploy execution commands into a compute environment of choice (e.g. local, cluster, cloud; Fig. 4a). Isabl applications are defined using python classes (Additional file 1: Fig. S8).
For example, variant calling applications will tailor execution parameters and reference datasets given the nature of the data (i.e. targeted gene sequencing, whole genome sequencing, etc.). Application results are stored as analyses (Fig. 4b). Each analysis is linked to results files and specific execution parameters. Analyses can compute on data for one or more targets and references experiments (e.g. single-target, tumor-normal pairs, target vs. pool of normals, etc.). Furthermore, analyses can also track numeric, Boolean, and text results using a PostgreSQL JSON Field. To warrant a full audit trail of results provenance and foster reproducibility, Isabl stores all analyses configurations (parameters, reference datasets, tool versions, etc.).
Upon completion of an analytical workflow, ownership of output files is automatically transferred to the admin user and write permissions are removed (see https://docs.isabl.io/writing-applications#applications-run-by-multiple-users). Once implemented, applications can be deployed system wide, on an entire project, or any subset of experiments in the database. A user-defined selection of results can be accessed through Isabl Web, which also indicates execution status, version, run time, storage usage, and linked experiments (Fig. 3c; Additional file 1: Fig. S3). If an analysis has already been executed, the system will prevent it's resubmission to minimize computing usage and prevent duplication.
To automate downstream analyses Isabl applications define logic to combine results at a project or individual level (Additional file 1: Fig. S9). For example, quality control reports, variant calls, or any other kind of result are merged within a single report (for each result type). The merge operation, at the project or individual level, is triggered automatically and runs only when required (i.e. not executed if other to-be-merged analyses are ongoing). Aggregated outputs are dynamically updated as new experiments are processed by the application. All auto-merge analyses are versioned and stored in Isabl DB.
Isabl CLI facilitates automations using signals, python functions triggered on status changes to execute subsequent tasks (Additional file 1: Fig. S9). For instance, a signal can be configured to deploy quality control applications upon data import. At QC success, another signal could deploy a complete suite of applications tailored to the nature of the experimental data. In case of automation failure, Isabl will send notifications to engineers via email, with error logs and instructions on how to restart the automation. Furthermore, Isabl API is equipped with an asynchronous tasks functionality useful to schedule backend work. For example, a task can be configured to sync metadata from institutional systems every 2 h.
Data access and results retrieval
Users can retrieve results using three main mechanisms: (1) visualization through Isabl Web; (2) programmatic data access with Isabl CLI; and, (3) direct data lake access (https://docs.isabl.io/retrieve-data). For each analysis, job execution status (i.e. pending, in progress, complete), as well as a defined list of results can be directly accessed through Isabl Web (with support for strings, numbers, text files, images, PDF, BAM, FASTA, VCF, PNG, HTML, amongst others; Additional file 1: Fig. S3). Isabl Web access to NGS data is further enabled using IGV.js (https://github.com/igvteam/igv.js; Fig. 3c). Additionally, Isabl CLI represents a programmatic means of entry to the entire data capital. A suite of command line utilities for metadata, data, and results retrieval is readily available. For example, queries can be constructed to identify samples of interest matching a range of attributes (i.e. patients, samples, analyses metadata) and retrieve specified results files (e.g. VCF files).
The codebase powering Isabl's client can be imported as a python package fostering systematic administration of data and analyses. For example, an analyst can import the SDK into a Jupyter  notebook to automatically access versioned algorithmic output for downstream post-processing, ensuring a full audit trail of data provenance from raw data to analysis and post-processing results. Moreover, Isabl CLI automatically creates and maintains easily accessible project directories with symbolic links pointing to all data and results, thus allowing access independently from the RESTful API (Additional file 1: Fig. S7c).
Integration of analytical applications into Isabl
Isabl as a bioinformatics framework is completely agnostic to bioinformatics pipelines and does not include pre-built applications (e.g. variant callers such as Pindel , Strelka ) or Workflow Management Systems (WMS; e.g. Bpipe , Toil ). Nevertheless, end-users can package, install, and deploy applications of choice in accordance with their data and operational requirements (e.g. https://github.com/isabl-io/demo). This enables full leverage of Isabl functionality while maintaining complete independence and flexibility in analytical workflows.
To facilitate seamless integration and rapid iteration of data processing pipelines into Isabl, we developed Toil Container and Cookiecutter Toil (Additional file 1: Fig. S10). Cookiecutter Toil (https://github.com/papaemmelab/cookiecutter-toil) is a templating utility that creates tools or pipelines with built-in software development best practices (i.e. version control, containerization, cloud testing, packaging, documentation; Additional file 1: Fig. S10a). On the other hand, Toil Container (https://github.com/papaemmelab/toil-container) enables Toil  class-based  pipelines to perform containerized system calls with both Docker and Singularity  without source code changes (Additional file 1: Fig. S10b). Toil Container ensures that analytical logic remains independent of execution logic by keeping pipelines agnostic to containerization technology or compute environment (e.g. an application can run using Docker in the cloud or Singularity in LSF; Additional file 1: Fig. S10c).
User roles and permissions
There are two levels to Isabl data access: interaction with metadata, and interaction with data.
Metadata. Users can create, retrieve, update, and delete metadata using Isabl Web and Isabl API. In order to manage these interactions, Isabl relies on Django Permissions (https://docs.djangoproject.com/en/3.1/topics/auth/default/#permissions-and-authorization). By assigning users to groups, the Isabl administrator can manage the actions granted towards different resources. Isabl offers 3 main roles: (1) Managers are users who can register samples, (2) analysts can run analyses, and (3) engineers can do both, register samples and run analyses. These roles are optional and customizable. Permissions can also be modified to each user specifically.
Data. The Isabl data lake can reside in the cloud or in a local file system. Access to these resources is not managed by Isabl but by a system administrator (i.e. Unix, Cloud). Users that have access to the data lake can execute applications if they have the right metadata permissions (e.g. create and update analyses). Once data is imported and analyses are finished, Isabl removes write permissions to prevent accidental deletion of data. Permissions to download and access data through Isabl Web are managed using Django Permissions.
We charted the end-to-end processes of bioinformatic operations and designed Isabl to address the major challenges in production-grade computational workflows. This includes the disruption of data silos, flexible integration to metadata sources, dynamic access and visualization of data, version control, audit trail, data harmonization, scalability, automation of analytical workflows and resource management (personnel as well as compute). We showcase how Isabl address these issues with the following case studies:
Case study 1: scalability and audit trail
Isabl has served as the bioinformatics backbone in our center, allowing us to scale up and compute upon data from 60K patients, organized in 200 independent projects. Isabl has supported the deployment of 300K analyses linked to 90 different data processing applications operating on + 300 TB of data—all in a versioned controlled data lake (Fig. 5a) [22,23,24,25,26,27,28,29,30]. Our Isabl instance maintains a real time audit trail of each step in the data generation process (Additional file 1: Video 1). Results and related metadata are accessible and visualized through Isabl CLI and Isabl Web. Figure 3a indicates the sustained growth in data footprint across time which by leveraging Isabl automations did not impose further demands on personnel.
Case study 2: meta analyses, data harmonization, and bugs correction
Meta analyses of existing data sets represent a powerful means to derive new insights. Datasets may be combined to improve statistical power or new algorithms can be executed across projects for novel readouts. For example, Isabl facilitated the fast registration and processing of + 35K patients from the MSK-IMPACT  cohort using a novel copy number analysis tool.
Samples metadata was ingested with Isabl API in less than an hour. Subsequently, the deployment of the new tool involved a two step process: (1) application registration; and (2) execution across samples that matched a specific criteria (i.e. targeted sequencing technique equals IMPACT ). More than 35K analyses were submitted with a single command and processed in 3 days with a + 5K cpu HPC cluster (Fig. 5b). Resulting output files were harmonized (same version) and organized under a specified project directory.
Similarly, these principles apply to error correction in analytical workflows. Upon discovery of an error or “bug”, Isabl enables the identification of all affected experimental data, re-execution of analyses with a corrected application, and identification of all relevant stakeholders for notification of data status. The pre-existing analyses are transferred to a time-stamped legacy directory. During results retrieval end-users have automatic access to the latest version of each analyses run, but if desired, can retrieve older analyses files from the legacy directory.
Case study 3: automation of analytical workflows
Isabl was used to implement an automated production-grade workflow for whole genome (WGS) and RNA analysis, executing > 30 independent algorithms automatedly (Fig. 6). Briefly, Isabl CLI and institutional API integrations facilitated the registration of FASTQ files from a sequencing core. Upon import, Isabl automations were used to deploy data processing applications (e.g. alignment, gene counts). Intermediate applications were subsequently executed as prior dependencies were satisfied (e.g. quality-control, variant calling). Last, derivation of summary statistics such as microsatellite instability  and homologous DNA recombination scores  that depend on primary data extraction (i.e. indels) were executed. Select data was embedded in a patient-centric report accessible through Isabl Web. Termed as the no-click genome, the entire process is executed with no manual intervention. In our center, these automations have enabled the discovery of novel diagnostic and therapy informing biomarkers within clinically relevant timeframes [24, 26].
Case study 4: multimodal data integration
Whilst Isabl was primarily designed for use cases derived from sequencing data, both platform and analysis paradigms make no assumptions about the nature of the data being registered. For a given individual, sequencing data as well as pathology data can be linked to specific samples  (Additional file 1: Fig. S2). The same is true for analysis applications, for example a tiling preprocessing step  could be productionized for new pathology images for a biopsy for which whole genome sequencing data is also produced. Analysis output files from image and whole genome sequencing variant calls are linked for a given individual. In this way, Isabl can facilitate the integration of diverse data modalities for downstream correlative analyses, which represents an area of increasing research focus.
Comparison to other platforms
Beyond Isabl, we have identified four published open source AIMS, (1) the Genome Modeling System (GMS) , (2) SeqWare , (3) QuickNGS  and (4) HTS-flow . Table 1 presents how these platforms compare across five main topics: Metadata Capabilities, Assets Management, Operational Automations, Results Accessibility, and Codebase Status. Although related, the One Touch Pipeline (OTP) , SevenBridges , FireCloud , and other service-based approaches are not considered here as their underlying infrastructures are private. We consider that Omics Pipe , Chipster , and GenePattern  are tools rather than AIMS frameworks. However, we recommend reviewing previous comparisons conducted by Ressinger , Bianchi , and Wagle .
Upon consideration of the comparison outlined in Table 1 and Additional file 1: Notes 1, Isabl's main differentiators are: (1) integration of a "RESTful API first" approach, (2) support for multimodal data, (3) an implementation agnostic to specific pipelines, workflow management systems, and storage and compute architectures, and 4. it's “plug and play” deployability and extensive documentation. Note that independently these features might not be unique to Isabl, yet the consolidation of all of these features into a single platform is. Importantly, Isabl does not provide integrations to LIMS systems out of the box, and deployment to cloud storage and compute systems require adaptation to the linked architectures.
To showcase Isabl's functionality we developed “10 min to Isabl” (https://docs.isabl.io/quick-start), a tutorial that guides end-users with a personal computer through platform installation, project registration, data import, application execution, and results retrieval.
The collective resources and funding required to support biospecimen collection and data generation in research is formidable. These efforts culminate in data that are mined to answer fundamental questions about human development, population attributes, disease biology and clinical decision support. Whilst sample collections are finite, the data capital if accessible in computable format can be leveraged across time. In the present study we propose the development of digital biobanks as companion infrastructures to support dynamic data access, processing and visualization of the growing data capital in research and healthcare.
To this end, we developed Isabl to support end-to-end bioinformatics operations. We showcase that with Isabl, real world challenges in computational biology, such as quality and version control, analysis audit trails, error correction, scalability, automation, and meta analyses can be readily addressed. To reduce the adoption barrier, the database schema can be customized and analysis tools can be added as Applications per end user specifications. To facilitate integration of analytical pipelines in accordance with best practices we further developed and made available Toil Container and Cookiecutter Toil. These templating utilities can be extended to include analyses pipelines for any data modality (NGS, single cell, imaging, etc.). Lastly, to position Isabl as a platform that facilitates and automates large scope institutional initiatives, we have developed a fully documented RESTful API and CLI for integration with biospecimens databases, clinical resources, visualization platforms, sequencing cores, and laboratory information management systems. Although Isabl adheres to the FAIR principles to a great extent, we recognize that the platform could adopt a standardized ontology like FHIR (https://www.hl7.org/fhir/) in the future.
From a strategic and operational perspective, implementation of computable digital biobanks is set to minimize costs by efficiently managing compute resources, reducing time to analyses and importantly demands for hands on operator time to process data. These automations at the same time maximize data deliverables, utilization of the data capital and reproducibility of findings. With the increasing aspiration to develop AI-driven approaches in healthcare and research, we showcase that the development of digital biobanks as AI-ready infrastructures will represent critical catalysts for research innovation, new discoveries, and clinical translation.
Availability and requirements
Project name: Isabl Platform
Project home page: https://github.com/isabl-io
Operating system(s): platform independent
Other requirements: Docker Compose
Licence: ad hoc license, free for academic and non-profit institutions
Any restrictions to use by non-academics: licence needed
Architecture and codebase
Isabl architecture is built upon separate codebases, which are loosely coupled and can be deployed independently in a plug-and-play fashion. For example, Isabl Web services only dependency is Docker Compose (https://docs.docker.com/compose; version 1.25.5), while the command line client is distributed using the Python Package Index (PyPi; https://pypi.org). Furthermore, Isabl's metadata infrastructure is decoupled and agnostic of compute and data storage environments (e.g. local, cluster, cloud). This functionality separates dependencies, fosters interoperability across data processing environments, and ensures that metadata is accessible even when the data is no longer available (FAIR A2 ). Isabl API is documented with ReDoc (https://platform.isabl.io/redoc/; https://github.com/Rebilly/ReDoc version 2.0.0; FAIR I3 ) following OpenAPI specifications (https://www.openapis.org; FAIR I2 ; FAIR R1.2 ).
Furthermore, Isabl is a framework. This means that Isabl API and Isabl CLI are installed as external dependencies, guaranteeing compatibility with future upgrades. As a result, end-users don't have to alter Isabl's source code to extend or modify the platform functionality (i.e. adding support for diverse data modalities such as imaging, radiology etc.).
Isabl API and CLI
Isabl's backend (Isabl API) was written in Python (http://www.python.org; version 3.7) using the Django (https://djangoproject.com; version 2.1.3) web framework as a reusable application (https://docs.djangoproject.com/en/2.1/ref/applications) so that users can install it as a dependency without the need to fork out from source code in order to extend their services. The django package was bootstrapped using Cookiecutter (https://github.com/audreyr/cookiecutter; version 1.7.2) from Cookiecutter Django Package (https://github.com/pydanny/cookiecutter-djangopackage; version 2.0.2). PostgreSQL (https://www.postgresql.org; version 10.1) was used to deliver Isabl's database. Django Taggit (https://github.com/alex/django-taggit; version 0.23.0) was used to support tagging capabilities. The RESTful API was implemented using Django REST Framework (DRF; www.django-rest-framework.org; version 3.8.2). The RESTful API swagger documentation was made available using drf-yasg (https://github.com/axnsan12/drf-yasg; version 1.16.1). Django Filter, DRF Filters, and DRF Query Fields were used to support advanced API filtering (https://github.com/philipn/django-rest-framework-filters version 1.0.0, https://github.com/carltongibson/django-filter version 2.0.0, and https://github.com/wimglenn/djangorestframework-queryfields version 1.0.0, respectively). RESTful API authentication was supported by Django Rest Auth (https://github.com/Tivix/django-rest-auth; version 0.9.2). Django Reversion was used to provide metadata version control (https://github.com/etianen/django-reversion; version 4.0.4). Excel files processing was conducted using XlsxWriter (https://github.com/jmcnamara/XlsxWriter; version 0.9.8). Isabl CLI was also bootstrapped with Cookiecutter from Cookiecutter PyPackage (https://github.com/audreyr/cookiecutter-pypackage; version 0.1.1). Command line functionalities were provided by Click (https://github.com/pallets/click; version 7.0) while mechanisms to conduct HTTP operations were brought by Requests (http://docs.python-requests.org; version 2.23.0).
Continuous integration, testing, and documentation
The RESTful API, database, and Web App were orchestrated using Docker Compose (https://docs.docker.com/compose; version 1.25.5) while all dependencies were resolved using Docker (https://www.docker.com; version 19.03.8). The Isabl CLI dependencies were limited to python libraries ensuring that the project was pip-installable (https://pypi.org/project/pip; version 20.1). All code repositories were Continuously Integrated (CI) using Travis CI (https://travis-ci.org), small code changes were merged frequently—rather than large changes at the end of development cycles. This was ensured by automatically running tests in the cloud upon every new code change. Testing was conducted and implemented with Pytest (https://docs.pytest.org; version 3.7.4) and tox (https://pypi.org/project/tox; version 2.9.1). Moreover, + 90% test coverage was guaranteed and automatically evaluated on the cloud using Coverage.py (https://pypi.org/project/coverage; version 4.4.2) and Codecov (https://codecov.io) for python projects. Extensive checks on documentation and code quality standards were ensured using ESLint (https://eslint.org; version 4.19.1), Pylint (https://www.pylint.org; version 1.8.1), and Pydocstyle (https://pypi.org/project/pydocstyle; version 2.1.1). Production code was homogenized and formatted with Black (https://github.com/ambv/black; version 18.9b0) and Prettier (https://prettier.io; version 1.12.1). Continuous Deployment (CD) of the components to their respective package managers and hosting sites was automatically conducted upon new releases. Both Isabl API and Isabl CLI were deployed to the Python Package Index (PyPi; https://pypi.org), while Isabl Web was deployed to npm (https://www.npmjs.com). Isabl's documentation is stored on GitHub (https://github.com/isabl-io/docs) and can be browsed at https://docs.isabl.io.
Cookiecutter toil and toil container
Cookiecutter Toil (https://github.com/papaemmelab/cookiecutter-toil) was forked from Cookiecutter PyPackage. Similarly to Isabl CLI, Toil Container (https://github.com/papaemmelab/toil_container) was bootstrapped with Cookiecutter PyPackage. The mechanisms to perform Docker (https://www.docker.com) and Singularity (https://singularity.lbl.gov; version 2.6) system calls were implemented as adaptations of Toil's apiDockerCall (https://github.com/DataBiosphere/toil/blob/d23f7ec46d2006c136a2a5b4e57eadfb44a606b7/src/toil/lib/docker.py#L199) and Toil-vg's singularityCall (https://github.com/vgteam/toil-vg/blob/48645cbf9c1e36c73abf2f731b3f06607185a5e9/src/toil_vg/singularity.py#L22). Toil Container was developed following the same standards and testing procedures of Isabl. Alike Isabl CLI, Cookiecutter Toil and Toil Container were deployed to PyPi.
Availability of data and materials
Isabl Platform is free for academic and non-profit institutions, source code can be requested at email@example.com.
Analysis information management system
Whole genome sequencing
Next generation sequencing
Command line interface
Single page application
High performance computing
Universally unique identifier
Software development kit
Workflow management system
Torkamani A, Andersen KG, Steinhubl SR, Topol EJ. High-definition medicine. Cell. 2017;170:828–43.
Riba M, Sala C, Toniolo D, Tonon G. Big data in medicine, the present and hopefully the future. Front Med. 2019;6:263.
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44–56.
Filipp FV. Opportunities for artificial intelligence in advancing precision medicine. Curr Genet Med Rep. 2019;7:208–13.
Griffith M, et al. Genome modeling system: a knowledge management platform for genomics. PLoS Comput Biol. 2015;11:e1004274.
Wagle P, Nikolić M, Frommolt P. QuickNGS elevates next-generation sequencing data analysis to a new level of automation. BMC Genom. 2015;16:487.
Quilez J, et al. Parallel sequencing lives, or what makes large sequencing projects successful. bioRxiv. 2017. https://doi.org/10.1101/136358.
Reisinger E, et al. OTP: an automatized system for managing and processing NGS data. J Biotechnol. 2017;261:53–62.
Bianchi V, et al. Integrated systems for NGS data management and analysis: open issues and available solutions. Front Genet. 2016;7:75.
Leipzig J. A review of bioinformatic pipeline frameworks. Brief Bioinform. 2017;18:530–6.
Cohen-Boulakia S, et al. Scientific workflows for computational reproducibility in the life sciences: status, challenges and opportunities. Future Gener Comput Syst. 2017;75:284–98.
Kulkarni P, Frommolt P. Challenges in the setup of large-scale next-generation sequencing analysis workflows. Comput Struct Biotechnol J. 2017;15:471–7.
Wilkinson MD, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016;3:160018.
Pittard WS, Li S. The essential toolbox of data science: Python, R, Git, and Docker. Methods Mol Biol. 2020;2104:265–311.
Chen, L. Microservices: architecting for continuous delivery and DevOps. In: 2018 IEEE International conference on software architecture (ICSA) (2018). https://doi.org/10.1109/icsa.2018.00013.
Perez F, Granger BE. IPython: a system for interactive scientific computing. Comput Sci Eng. 2007;9:21–9.
Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics. 2009;25:2865–71.
Saunders CT, et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28:1811–7.
Sadedin SP, Pope B, Oshlack A. Bpipe: a tool for running and managing bioinformatics pipelines. Bioinformatics. 2012;28:1525–6.
Vivian J, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35:314–6.
Kurtzer GM, Sochat V, Bauer MW. Singularity: scientific containers for mobility of compute. PLoS ONE. 2017;12:e0177459.
Rustad EH, et al. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma. Am J Hematol. 2019a. https://doi.org/10.1002/ajh.25641.
Rustad EH, et al. Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma. PLoS ONE. 2019b;14:e0211600.
Slotkin EK, et al. Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel fusion-driven cancer. Cancer Discov. 2019;9:605–16.
Kazandjian D, et al. Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients. Blood Cancer J. 2019;9:15.
Diolaiti D, et al. A recurrent novel fusion identifies a new subtype of high-grade spindle cell sarcoma. Cold Spring Harb Mol Case Stud. 2018;4:a003194.
Ledergor G, et al. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat Med. 2018;24:1867–76.
Xiao W, et al. Mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation. Blood Adv. 2018;2:3526–39.
Bolton KL, et al. Oncologic therapy shapes the fitness landscape of clonal hematopoiesis. bioRxiv. 2019. https://doi.org/10.1101/848739.
Bernard E, et al. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. bioRxiv. 2019. https://doi.org/10.1101/2019.12.19.868844.
Zehir A, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23:703–13.
Niu B, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics. 2014;30:1015–6.
Davies H, et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med. 2017;23:517–25.
Fu Y, et al. Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis. Nat Cancer. 2020. https://doi.org/10.1101/813543.
Barker J, Hoogi A, Depeursinge A, Rubin DL. Automated classification of brain tumor type in whole-slide digital pathology images using local representative tiles. Med Image Anal. 2016;30:60–71.
O’Connor BD, Merriman B, Nelson SF. SeqWare query engine: storing and searching sequence data in the cloud. BMC Bioinform. 2010;11(12):S2.
Correction: The cancer genomics cloud: collaborative, reproducible, and democratized-a new paradigm in large-scale computational research. Cancer Res. 2018;78:5179.
Birger C, et al. FireCloud, a scalable cloud-based platform for collaborative genome analysis: strategies for reducing and controlling costs. bioRxiv. 2017. https://doi.org/10.1101/209494.
Fisch KM, et al. Omics Pipe: a community-based framework for reproducible multi-omics data analysis. Bioinformatics. 2015;31:1724–8.
Kallio MA, et al. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genom. 2011;12:507.
Reich M, et al. GenePattern 2.0. Nat Genet. 2006;38:500–1.
We would like to acknowledge Gaelle Ougourni, Franck Rappaport, Ross Levine, Minal Patel, Kristina Jack, Erin McGovern, Chris Famulare, Irene Sanchez, Nancy Bouvier, Andrew McPherson, Arfath Pasha, Daniel Leongonmornlet, Nicole Rusk and members of the Papaemmanuil Laboratory, Computational Oncology, Center for Heme Malignancies and Department of Pediatrics for input on system design, functionality and system testing.
Isabl's development was supported by the Sohn Conference Foundation and the Olayan Fund for Precision Pediatric Cancer Medicine and institutional funds to support bioinformatics operations for the center for heme malignancies at Memorial Sloan Kettering Cancer Center. Elli Papaemmanuil is a Josie Robertson Investigator and is supported by the European Hematology Association, American Society of Hematology, Gabrielle’s Angels Foundation, the V Foundation, The Geoffrey Beene Foundation and is a recipient of a Damon Runyon-Rachleff Innovators award. The declared funding provided salary support to support Bioinformatics operations for the Department of Pediatrics and the Center for Hematological Malignancies at Memorial Sloan Kettering Cancer Center. The funding bodies were not involved in study design collection, analysis and interpretation of data or in writing the manuscript.
Ethics approval and consent to participate
Consent for publication
JSM, EP, and AK are founders of Isabl a whole genome analytics company.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Medina-Martínez, J.S., Arango-Ossa, J.E., Levine, M.F. et al. Isabl Platform, a digital biobank for processing multimodal patient data. BMC Bioinformatics 21, 549 (2020). https://doi.org/10.1186/s12859-020-03879-7
- Data processing
- Analysis information management system
- Next generation sequencing
- Image processing
- Software engineering
- Multimodal data